Embecta is a global medical device company that designs and manufactures sterile injection devices and related products for diabetes care, including pen needles, syringes, and safety devices used by millions of patients across more than 100 countries. The company generates revenue by selling these products through retail, hospital, pharmacy, and institutional channels worldwide, serving both individual end users and healthcare providers. Embecta competes in a dynamic and innovative diabetes care market on the basis of product quality, clinical differentiation, pricing, and service; it pursues growth through research and development improvements to existing products, exploration of adjacent markets in drug delivery and chronic care, and strategic acquisitions and partnerships to access new technologies and geographies.